Whole exome sequencing of familial hypercholesterolaemia patients negative for LDLR/APOB/PCSK9 mutations.
BACKGROUND: Familial hypercholesterolaemia (FH) is an autosomal dominant disease of lipid metabolism, which leads to early coronary heart disease. Mutations in LDLR, APOB and PCSK9 can be detected in 80% of definite FH (DFH) patients. This study aimed to identify novel FH-causing genetic variants in...
Main Authors: | Futema, M, Plagnol, V, Li, K, Whittall, R, Neil, H, Seed, M, Bertolini, S, Calandra, S, Descamps, O, Graham, C, Hegele, R, Karpe, F, Durst, R, Leitersdorf, E, Lench, N, Nair, DR, Soran, H, Van Bockxmeer, F, Humphries, SE |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado: |
BMJ Publishing Group
2014
|
Títulos similares
-
Healthy individuals carrying the PCSK9 p.R46L variant and familial hypercholesterolemia patients carrying PCSK9 p.D374Y exhibit lower plasma concentrations of PCSK9.
por: Humphries, SE, et al.
Publicado: (2009) -
The utility of DNA-based testing in patients with familial hypercholesterolaemia in the UK
por: Humphries, SE, et al.
Publicado: (2005) -
Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction.
por: Do, R, et al.
Publicado: (2014) -
Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study.
por: Talmud, P, et al.
Publicado: (2013) -
Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: A case-control study
por: Talmud, P, et al.
Publicado: (2013)